Expired
Lead Plaintiff Deadline
May 17, 2021
Choose your preferred way to stay informed of new case launches and settlement deadlines
while BLU-5937’s “high selectivity” contributed to the drug causing little to no taste alteration in chronic cough patients, that high selectivity also contributed to the drug potentially being less efficacious and thus likely not be able to meet the primary endpoint of the Company’s Phase 2 trial.
In order to be eligible to join the BLU class action lawsuit, you must have incurred a loss on shares of BELLUS Health purchased during the class period listed above.
If you suffered a loss in BELLUS Health during the relevant time frame or pursuant to the relevant offering(s), you have until May 17, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
TOP
